Shell Asset Management CO United Therapeutics Corp Transaction History

Shell Asset Management CO

$2.27 Billion
Q3 2024

A detailed history of Shell Asset Management CO transactions in United Therapeutics Corp stock. As of the latest transaction made, Shell Asset Management CO holds 2,568 shares of UTHR stock, worth $926,714. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,568

Previous 3,274 21.56%

Holding current value

$926,714

Previous $1.04 Million 11.79%

% of portfolio

0.04%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$311.04 - $363.55 $219,594 - $256,666	-706 Reduced 21.56%	2,568 $920,000
Q1 2024 Jul 31, 2024	SELL	$210.76 - $249.51 $45,734 - $54,143	-217 Reduced 6.22%	3,274 $1.04 Million
Q1 2024 May 14, 2024	BUY	$210.76 - $249.51 $331,103 - $391,980	1,571 Added 81.82%	3,491 $802,000
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $123,341 - $147,483	-574 Reduced 23.02%	1,920 $422,000
Q3 2023 Nov 08, 2023	SELL	$211.82 - $248.24 $9,108 - $10,674	-43 Reduced 1.69%	2,494 $563,000
Q2 2023 Jul 28, 2023	SELL	$205.19 - $232.99 $289,933 - $329,214	-1,413 Reduced 35.77%	2,537 $560,000
Q1 2023 May 15, 2023	SELL	$212.99 - $276.17 $2,981 - $3,866	-14 Reduced 0.35%	3,950 $885,000
Q4 2022 Feb 07, 2023	SELL	$205.95 - $280.43 $169,908 - $231,354	-825 Reduced 17.23%	3,964 $1.1 Million
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $255,141 - $306,433	-1,255 Reduced 20.76%	4,789 $1 Million
Q2 2022 Aug 09, 2022	BUY	$174.81 - $241.14 $1,922 - $2,652	11 Added 0.18%	6,044 $1.42 Million
Q1 2022 May 04, 2022	SELL	$166.16 - $213.96 $148,380 - $191,066	-893 Reduced 12.89%	6,033 $1.08 Million
Q4 2021 Feb 09, 2022	BUY	$184.32 - $216.08 $6,635 - $7,778	36 Added 0.52%	6,926 $1.5 Million
Q3 2021 Nov 04, 2021	SELL	$179.86 - $214.88 $53,958 - $64,464	-300 Reduced 4.17%	6,890 $1.27 Million
Q2 2021 Aug 12, 2021	BUY	$170.47 - $211.93 $188,369 - $234,182	1,105 Added 18.16%	7,190 $1.29 Million
Q1 2021 May 10, 2021	BUY	$153.94 - $174.85 $240,300 - $272,940	1,561 Added 34.5%	6,085 $1.02 Million
Q3 2020 Nov 13, 2020	BUY	$99.9 - $121.13 $227,672 - $276,055	2,279 Added 101.51%	4,524 $457,000
Q2 2020 Aug 10, 2020	BUY	$92.74 - $125.82 $208,201 - $282,465	2,245 New	2,245 $272,000
Q2 2019 Aug 12, 2019	SELL	$76.06 - $120.81 $74,310 - $118,031	-977 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$107.15 - $126.84 $34,716 - $41,096	-324 Reduced 24.9%	977 $115,000
Q4 2018 Feb 13, 2019	SELL	$101.4 - $128.73 $173,292 - $219,999	-1,709 Reduced 56.78%	1,301 $142,000
Q3 2018 Nov 13, 2018	BUY	$113.81 - $129.46 $108,347 - $123,245	952 Added 46.26%	3,010 $385,000
Q1 2018 May 14, 2018	SELL	$107.21 - $151.94 $948,808 - $1.34 Million	-8,850 Reduced 81.13%	2,058 $231,000
Q4 2017 Feb 09, 2018	SELL	$118.58 - $151.28 $624,798 - $797,094	-5,269 Reduced 32.57%	10,908 $1.61 Million
Q3 2017 Oct 20, 2017	SELL	$114.6 - $136.81 $1.99 Million - $2.37 Million	-17,327 Reduced 51.72%	16,177 $1.9 Million
Q3 2017 Oct 18, 2017	BUY	$114.6 - $136.81 $3.84 Million - $4.58 Million	33,504	33,504 $4.31 Million

Others Institutions Holding UTHR

# of Institutions

671

Shares Held

42.3M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO United Therapeutics Corp Transaction History